Lawmakers in the state of Maine approved a part of legislation that would give 16-and-17-year-olds the ability to undergo hormone therapy for gender transitions without parental consent.
The company's shares have dropped by 9.21% on the New York Stock Exchange (NYSE) since last month, following controversy regarding their so-called "Pride Month" collection which includes merchandise related to the LGBTQ+ community.
"Our meta-analysis highlights a link between SARS-CoV-2 vaccination and new onset or worsening of inflammatory and autoimmune skin diseases," the study authors write.